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Background: The Paris System (TPS) introduced diagnostic criteria for urine cytology to improve
reproducibility among pathologists. Thus far, most cytology studies have investigated applica-
tion of TPS on lower urinary tract specimens. Also, it is unclear which cytologic features are
most predictive of malignancy, particularly in the upper urinary tract. We evaluate concordance
rates of preoperative upper urinary tract cytology specimens before and after application of TPS
criteria with surgical resections and assess cytologic features associated with malignancy.
Design: 54 resections with high- and low-grade urothelial carcinoma (HGUC, LGUC) from 2000-2016
with available preoperative cytology (n = 61) were identified. Cytology was re-reviewed to evaluate
cytologic features and provide diagnoses before and after TPS implementation.
Results: The most common cytologic features associated with HGUC were N:C ratios ≥0.7 (88%),
hyperchromasia (83%), coarse chromatin distribution (67%), and nuclear pleomorphism in cell clus-
ters (65%). Application of TPS criteria resulted in 10 diagnostic downgrades and 6 diagnostic
upgrades. After TPS criteria were applied, the sensitivity of a positive diagnosis decreased from 29%
to 19%. The morphologic feature most consistently associated with a downgrade from positive to
suspicious was a lack of marked nuclear contour irregularities in atypical urothelial cells.
Conclusion: Using strict TPS criteria in upper urinary tract cytology specimens may decrease
the frequency of positive diagnoses with a concurrent increase in suspicious diagnoses. These
findings may indicate that different morphologic features, particularly markedly irregular nuclear
contours, may have different predictive values for HGUC in upper urinary tract cytology speci-
mens compared with those from the lower urinary tract.
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1 | INTRODUCTION
Primary cancers of the urinary tract represent the ninth most common
site of cancer worldwide.1 Upper tract urothelial cancers (UTUC) are
relatively rare, accounting for approximately 5%-10% of all urothelial
cell carcinomas and 5%-7% of renal neoplasms.2 When compared with
urothelial carcinomas of the lower urinary tract, UTUC are less com-
mon, but also confer a worse prognosis, leading to an estimated
15,930 deaths in the United States in 2018.3 Additionally, the propen-
sity of urothelial carcinoma for recurrence and multifocality results in
increased surveillance and monitoring to guide patient management.
As such, urothelial carcinoma results in the highest lifetime financial
cost for a patient of any cancer.4
Although voided urine cytology (VUC) has been shown to be a
convenient method of diagnosing high-grade urothelial carcinoma
(HGUC) in the lower urinary tract, diagnosing upper urinary tract
HGUCs by VUC is limited by poor cellular preservation and mechani-
cal distortion.5,6 Additionally, the increased technical difficulty in visu-
alizing and accessing potential tumors in the upper urinary tract in
comparison to those arising in the lower urinary tract also makes
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acquisition of diagnostic material by biopsy more difficult.7 These fac-
tors highlight the utility of upper urinary tract washing cytology speci-
mens, as there is a wider area of urothelium evaluated during an
upper tract washing compared with a focused biopsy. Furthermore,
cytologic atypia in upper urinary tract HGUC are more prominently
featured in upper tract cytology washes in comparison to VUC due to
better cellular preservation.
However, the utility of urine cytology has historically been limited
by the variable usage of indeterminate categories such as “atypical”
and “suspicious,” which in turn leads to confusion as to what manage-
ment options should be pursued by the clinicians. As such, there have
previously been several attempts to standardize diagnoses in urine
cytology by various classification schema.8 Currently, the most formal
and widely utilized classification system has been the recently pub-
lished Paris System for Urine Cytology.
The Paris System (TPS) introduced diagnostic morphologic
criteria for urine cytology to improve reproducibility among patholo-
gists and potentially help establish management guidelines. Thus
far, many cytology studies have focused on the application of TPS
on urine specimens from the lower urinary tract. Additionally, there
is still uncertainty as to which cytologic features are most predictive
of malignancy, particularly in upper tract urine cytology. This study
evaluates the concordance rates of preoperative upper tract urine
cytology specimens before and after application of TPS criteria with
surgical resection specimens as well as cytologic features most pre-
dictive of malignancy.
2 | MATERIALS AND METHODS
With Institutional Review Board approval, 114 patients with a diagno-
sis of upper urinary tract urothelial carcinoma who had undergone
radical nephroureterectomy or ureterectomy between 2000 and 2016
were retrospectively identified from the surgical pathology archive at
Michigan Medicine. Of these, 59 patients had both surgical pathology
and pre-operative urine cytology specimens (ThinPrep) available for
review for a total of 61 resections and 111 cytology specimens.
Patients with non-diagnostic cytologic specimens, no residual disease
on surgical resection, and/or only voided or urinary bladder washing
urine cytology (no upper tract urine cytology) were excluded from the
cohort. Also, cases in which the pre-operative urine cytology speci-
mens were collected only from the contralateral side of the ulti-
mate surgical resection or were collected over a year from the date
of surgical resection were excluded from the cohort. This left a
total of 53 patients with 54 resections and 72 cytology specimens.
In this cohort, there were 7 patients who had more than 1 upper
urinary tract cytology specimen collected concurrently from the
same site. A total of 4 patients had 2 concurrent samples, 2 patients
had 3 concurrent samples, and 1 patient had 4 concurrent samples.
In these instances, the urine cytology with the most severe diagno-
sis for each of these patients was used for analysis. These final
parameters left a total of 53 patients with 54 resections and
61 urine cytologic specimens for evaluation.
The cytology materials were reviewed by a cytopathologist (M.L.)
who was blinded to patient demographics and clinicopathologic data.
The cytopathologist evaluated each cytology specimen and provided
diagnoses before and after application of diagnostic criteria put forth
by TPS. In the initial evaluation of urine specimens before application
of TPS criteria, the diagnostic categories of “no malignant cells
identified,” “atypical urothelial cells,” “suspicious for urothelial
carcinoma,” and “positive for urothelial carcinoma” were utilized. After
initial evaluation, diagnostic criteria of TPS were applied to catego-
rize lesions as either “negative for HGUC,” “atypical urothelial cells,”
“suspicious for HGUC,” “positive for HGUC,” or “low-grade urothelial
neoplasm”. Cytologic features including increased nuclear to cyto-
plasmic (N:C) ratios, nuclear hyperchromasia, irregular nuclear
contours, coarse chromatin distribution, and nuclear pleomorphism
as well as the presence of mitotic figures, urothelial cells with atypi-
cal degeneration, and bizarre single cells were recorded for each
specimen. The frequency of changed diagnoses before and after
application of TPS diagnostic criteria, concordance with subsequent
surgical resection specimens (which was considered to be the gold
standard for each patient), and the presence of distinct cytologic fea-
tures in patients with subsequent resections were evaluated. Slides
from the surgical resections were reviewed by 3 study pathologists
(C.T.S., S.L.S. and R.M.) to confirm the pathologic features including
the diagnosis, grade, and stage.
Associations between the cytologic diagnoses, features, and re-
section grade were examined using the χ2 test or Fisher's exact
test, as indicated; a P-value of < .05 was considered to be statisti-
cally significant.
3 | RESULTS
Demographic data from the patient cohort is summarized in Table 1.
Of the 53 patients, 44 were male (83%). Patient age ranged from
47-94 years at the time of surgical resection. In total, 13 of the
patients had either received either neoadjuvant chemotherapy (8%) or
adjuvant therapy (17%). Disease progression was noted as clinical
recurrence in 20 patients (38%) and 10 (19%) patients had definitive
metastasis (4 patients with urothelial carcinoma involving 1 metastatic
site, 3 patients with 2 metastatic sites, 1 patient with 3, 1 patient with
4, and 1 patient with 5). The most common metastatic site was lung
(6 cases), followed by liver (5 cases), bone (4 cases), kidney (2 cases),
TABLE 1 Demographics for 53 patients
Gender n (%) Male 44 (83%)
Female 9 (17%)
Age (years) Range 47–94
Mean 69
Median 69
Therapy n (%) Neoadjuvant chemotherapy 4 (8%)
Adjuvant therapy 9 (17%)
Previous cystectomy
for bladder cancer n (%)
7 (13%)
Outcomes n (%) Recurrence 20 (38%)
Metastasis 10 (19%)
Time to last follow up (days) Range 7-3635
Mean 1176
422 SIMON ET AL.
soft tissue (2 cases), axillary lymph nodes (2 cases), and prostate (1 case).
The time to last clinical follow-up ranged from 7 to 3635 days.
Of the 54 surgical resections evaluated, 23 were from the right
(43%) and 31 were from the left side (57%). The majority of these
resections were diagnosed as HGUC (n = 41, 76%), while low-grade
urothelial carcinoma (LGUC) was diagnosed in the remaining cases
(n = 13, 24%). The resection specimen data is summarized in Table 2.
A total of 61 ipsilateral urine specimens collected 5-323 days
prior to resection were evaluated before and after application of
diagnostic criteria put forth by TPS. Table 3 summarizes cytologic
specimen collection data. Application of TPS criteria resulted in a
change of diagnosis in 16 (26%) cases. Of these, 16 cases, 10 (63%)
were diagnostic downgrades while the remaining 6 (37%) resulted in
diagnostic upgrades. Of the 6 upgrades, 3 (50%) represented a change
from the atypical to suspicious category, 2 (33%) represented a
change from the negative to atypical category, and 1 (17%) repre-
sented a change from suspicious to positive. Of the 10 downgrades,
the most common change was from positive to suspicious (6, 60%).
The remaining 4 downgrades were split between downgrades from
suspicious to atypical and atypical to negative. Table 4 summarizes
the results of applying TPS criteria to the upper tract urine specimens
on diagnostic rates of all diagnostic categories.
The frequency of cytologic features associated with subse-
quent LGUC and HGUC on surgical resection was evaluated. The
presence of coarse chromatin distribution among atypical urothelial
cells (Figure 1A,C) and bizarre single cells were seen more com-
monly in HGUC in comparison to LGUC; these findings were statis-
tically significant. In contrast, nuclear to cytoplasmic ratios, nuclear
hyperchromasia, nuclear contour irregularities, pleomorphism, as
well as the presence of mitoses and/or atypical degeneration were
not statistically significant features in differentiating between
LGUCs and HGUCs (Table 5).
The concordance rate between cytologic diagnoses and the sub-
sequent surgical resection was evaluated. The sensitivity of a positive
diagnosis in upper urinary tract cytology in the detection of HGUC
prior to the application of TPS criteria was 29% and decreased to 19%
after application of TPS criteria. However, the sensitivities in detect-
ing HGUC are more similar after suspicious and atypical categories
were included into the “positive” cohort (sensitivities of 60% when
including the suspicious category into the “positive” cohort before and
after application of TPS criteria, sensitivities of 88% and 85% after
including both suspicious and atypical categories in the “positive
cohort” before and after application of TPS criteria, respectively). For
LGUC, the sensitivity of upper urinary tract urine cytology is much
lower than that for HGUC, which is expected given that the primary
focus of urine cytology stated by the TPS is the detection of HGUC.
Evaluation of upper urinary tract cytology both before and after
application of TPS shows higher sensitivity in the detection of HGUC
in comparison to LGUC. The sensitivities of upper urinary tract cytol-
ogy before and after application of TPS are shown for each diagnostic
category in Table 6.
Of the 6 cases that were upgraded after application of TPS, all
displayed N:C ratios ≥0.7 and nuclear hyperchromasia. The 1 case that
was upgraded from suspicious to positive showed all key diagnostic
features of HGUC highlighted in TPS criteria (N:C ratio ≥ 0.7, nuclear
hyperchromasia, and coarse chromatin distribution) in cells with rela-
tively small nuclei (Figure 2A,B). Of the 10 cases that were down-
graded with application of TPS, 8 cases (80%) showed N:C ratios ≥0.7,
nuclear hyperchromasia, and pleomorphism. In our cohort, 6 of the
10 downgraded cases (60%) represented changes from positive to
suspicious diagnostic categories. In these cases, the cells displayed
N:C ratios ≥0.7, nuclear hyperchromasia, and coarse chromatin dis-
tribution, but lacked markedly irregular nuclear contours (Figure 3A,
E) seen in other cases diagnosed as positive for HGUC (Figure 4A,B).
All 10 (100%) of the cases that were downgraded were diagnosed as
HGUC on resection, compared with 4 of 6 (66%) cases that were
upgraded after application of TPS criteria.
4 | DISCUSSION
Prior to TPS, the institutional diagnostic rate of atypical urine cytology
ranged from 2% to 31% with 8.3-37.5% of these cases associated
with a subsequent histologic diagnosis of HGUC.9–11 Taking note of
the inconsistent utilization of the “atypical” category in urine cytology
and its variable association with subsequent urothelial carcinoma diag-
noses on biopsies/resections, the authors of TPS established the goal
of creating diagnostically more reproducible and, hopefully, more clini-
cally meaningful diagnostic categories.
The utilization of TPS has yielded variable results, most of
which are favorable, after implementation across institutions. Some
institutions have noted that the most significant change seen from
pre to post-Paris System evaluation lies in the diagnostic rate of
the indeterminate category of “atypical” and, to a lesser degree, the
“suspicious” category. Although many institutions have displayed a
decreased atypical diagnostic rate after implementing TPS diagnos-
tic criteria,9,12,13 few have reported no significant changes in the
rate of atypical urine cytology14 and rare others have reported an
increased atypical rate.15 Of note, many of the studies that showed
a decrease in diagnostic rates of “atypical” urine cytology also
reported an increased association of these “atypical” cases with
TABLE 2 Surgical resections for upper tract urothelial carcinoma
N = 54 n (%)
Laterality Right 23 (43)
Left 31 (57)
Grade Low 13 (24%)
High 41 (76%)
TABLE 3 Cytology specimen summary
Total number of upper tract cytology
specimens within 1 year of resection
61
Cytology specimens per resection n (%) 1 47 (87%)
2 7 (13%)
Site of urine cytology collection n (%) Renal pelvis 37 (61%)
Ureter 24 (39%)
Time from proximal cytology specimen to
surgical resection (days)
Range 5-323
Mean 66
Median 45
SIMON ET AL. 423
subsequent histologic diagnoses of HGUC. Additionally, several studies
have noted the improvement in correlation of urinary cytology when
using TPS classification with subsequent biopsy diagnoses.12,14,16,17
However, while many of these studies have focused on the evaluation
of urine cytology specimens derived from voided urines or bladder
washings evaluating the lower urinary tract, there have few studies
with a predominant focus on upper urinary tract cytology.
In our current study focusing on upper urinary tract cytology, the
most common cytologic features associated with HGUC on subsequent
resections were N:C ratios ≥0.7 (88% of urine cytology cases from
patients with subsequent HGUC on resection), hyperchromasia (83%),
coarse chromatin distribution (67%), and nuclear pleomorphism within
cell clusters (65%). Application of TPS diagnostic criteria resulted in a
slightly increased use of the suspicious diagnostic category (26% to
36%) with no significant change in the diagnostic rate of the atypical
diagnostic category. Zheng et al.,18 also evaluated the effect of utiliz-
ing TPS in 125 upper urinary tract urine cytology specimens from
74 patients who had subsequent biopsies or resections within
2 months of upper urinary tract urine collection. In this study, the
diagnostic rates in this cohort for non-diagnostic, negative for
HGUC, atypical urothelial cells, low-grade urothelial neoplasm, suspi-
cious for HGUC, and positive for HGUC were 1.6%, 39.2%, 17.6%,
TABLE 4 Cytology diagnoses before and after application of Paris System Criteria
TPS diagnosis Negative for HGUC Atypical Suspicious for HGUC Positive for HGUC Total
Original diagnosis
NMCI 9 (15%) 2 (3%) 0 (0%) 0 (0%) 11 (18%)
Atypical 2 (3%) 14 (23%) 3 (5%) 0 (0%) 19 (31%)
Suspicious for UC 0 (0%) 2 (3%) 13 (21%) 1 (2%) 16 (26%)
Positive for UC 0 (0%) 0 (0%) 6 (10%) 9 (15%) 15 (25%)
Total 11 (18%) 18 (29%) 22 (36%) 10 (17%) 61 (100%)
Abbreviations: HGUC, high-grade urothelial carcinoma; NMCI, negative for malignant cells; UC, urothelial carcinoma.
FIGURE 1 Atypical urothelial cells display coarse chromatin distribution as well as nuclear pleomorphism with cell clusters (ThinPrep, 400×
magnification—A, ThinPrep, 600× magnification—B,C) [Color figure can be viewed at wileyonlinelibrary.com]
TABLE 5 Cytologic features of upper tract urine cytology specimens in HGUC and LGUC
No. of
atypical cells N:C≥ 0.7
Nuclear
hyperchromasia
Nuclear contour
irregularity
Coarse
chromatin Pleomorphism Mitoses
Atypical
degeneration
Bizarre
single cells
HGUC (n = 48) ≤10:15 (31%) 42 (88%) 40 (83%) 11 (23%) 32 (67%) 31 (65%) 6 (13%) 7 (15%) 18 (38%)
11-20:9 (19%)
>20:14 (50%)
LGUC (n = 13) ≤10:8 (62%) 10 (77%) 9 (69%) 4 (31%) 1 (7%) 5 (36%) 0 (%) 0 (0%) 1 (7%)
11–20:2 (15%)
>20:3 (23%)
P N/A 0.340 .257 .560 <.001 .089 .326 .328 .040
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8.8%, 16.8%, and 16%, respectively. However, the study did not
evaluate the diagnostic rates of these categories prior to implemen-
tation of TPS diagnostic criteria. Zheng et al., also reported higher
sensitivity for the detection of HGUC when cytology was diagnosed
as positive for HGUC than our study (45% vs 19%). However, similar
to our study, the sensitivity significantly increased when both suspi-
cious and positive were considered “positive” (78.6% vs 60%,) and
even more so when the atypical diagnostic category is also consid-
ered as part of the positive cohort (92.9% vs 85%). In a more recent
study by McIntire et al.,19 implementation of TPS criteria also
resulted in an improved correlation of upper urinary tract cytology
specimens with subsequent biopsies (from 34% to 63%) and a
decreased use in of the atypical diagnostic category (from 29% to
13%). However, in contrast to our current study, the pre-TPS original
diagnoses were gathered from the prior pathology reports and were
not re-reviewed and distinct cytologic features of the urine speci-
mens were not evaluated.
As noted previously in our results, there was a diagnostic cate-
gory change after application of TPS criteria in 16 (26%) cases, 10 of
which represent diagnostic downgrades while the others represent
diagnostic upgrades. The most common upgrade was seen in cases
originally diagnosed as atypical and then called suspicious for HGUC
after TPS criteria were applied (50%, 3 of 6 upgrades) while the most
common downgrade was seen in cases originally diagnosed as positive
for urothelial carcinoma and then called suspicious for HGUC after
strict TPS criteria were applied (60%, 6 of 10 downgrades). Upon re-
review of the cases resulting in diagnostic changes, we found that the
1 case resulting in an upgrade from suspicious for urothelial carcinoma
to positive for HGUC after application of TPS criteria displayed
TABLE 6 Sensitivity of upper tract urine cytology in detecting HGUC
and LGUC
HGUC LGUC LG and HG
Original diagnosis
Positive 0.29 0.08 0.25
Positive + suspicious 0.60 0.15 0.59
Positive + suspicious + atypical 0.88 0.62 0.82
TPS diagnosis
Positive 0.19 0.08 0.16
Positive + suspicious 0.60 0.21 0.52
Positive + suspicious + atypical 0.85 0.69 0.82
Abbrviations: HGUC, high-grade urothelial carcinoma; LGUC, low-grade
urothelial carcinoma.
FIGURE 2 Features of case associated with diagnostic upgrade from suspicious to positive after application of TPS criteria. Atypical urothelial
cells display N:C ratios >0.7, nuclear hyperchromasia, coarse chromatin distribution, and nuclear contour irregularity. However, the overall nuclear
size is not markedly enlarged compared with background benign urothelial cells (ThinPrep, 200× magnification—A, 400× magnification—B) [Color
figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 Features of cases associated with diagnostic downgrade from positive to suspicious after application of TPS criteria. Atypical
urothelial cells display increased N:C ratios, nuclear hyperchromasia, prominent nucleoli, and coarse chromatin distribution, but lack marked
nuclear contour irregularity (ThinPrep, 400x magnification—A,B, 600× magnification—C–E) [Color figure can be viewed at wileyonlinelibrary.com]
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atypical urothelial cells with N:C ratios ≥0.7, coarse chromatin distri-
bution, nuclear hyperchromasia, and nuclear contour irregularity in
cells; however, these features were seen in urothelial cells with rela-
tively small nuclei compared with surrounding benign urothelial cells
(Figure 2A,B). Additionally, the most consistent feature associated
with a diagnostic downgrade from positive for urothelial carcinoma to
suspicious for HGUC was the lack of marked nuclear contour irregu-
larity in atypical urothelial cells (Figures 3A,E), one of the key Paris
System diagnostic features of malignant urothelial cells. This finding
highlights how strict application of TPS criteria for upper urinary tract
cytology specimens can decrease the frequency of positive diagnoses.
Our findings may indicate that different morphologic features,
particularly markedly irregular nuclear contours, may have different
predictive values for HGUC in upper urinary tract urine cytology
specimens compared with those from the lower urinary tract. How-
ever, there are limitations to this current study, including the retro-
spective nature of patient selection. This could provide a source
of selection bias, as slides were reviewed knowing that subsequent
resection specimens had either LGUC or HGUC. As such, mild cyto-
logic features may be more carefully evaluated. Additionally, the
cytology specimens were only re-reviewed by 1 cytopathologist
during the study, which does not allow for a consensus opinion.
Nonetheless, if similar findings are validated by other independent
studies, future iterations of TPS may consider revision of diagnostic
criteria, particularly for upper tract urine specimens.
Suh et al., evaluated 142 urinary tract washing specimens derived
from the urinary bladder, ureter, and renal pelvis for cytologic features
(including anisonucleosis, India ink nuclei, apoptotic bodies, increased
N:C ratios, irregular nuclear membranes, coarse chromatin, hyperchro-
masia, pleomorphism, tumor diathesis) associated with HGUC. After
regression analyses, anisonucleosis and India ink nuclei were reported
to be independent predictors for HGUC. The authors then applied a
modified TPS to include these 2 features, which resulted in an
increased sensitivity in the detection of HGUC without a significant
loss in specificity. Another study of 112 urinary tract cytology speci-
mens from patients with a subsequent diagnosis of HGUC on tissue
biopsy by Cowan et al.20 noted that strict application of TPS criteria
(requiring the presence of a N:C ratio ≥ 0.7, nuclear hyperchromasia,
markedly irregular nuclear contours, and coarse chromatin distribution
as well as a minimum quantity of atypical urothelial cells with the
aforementioned features) could potentially restrict a diagnosis of
HGUC. Although the study showed that N:C ratio ≥ 0.7 was the
most stringent TPS diagnostic criteria (78%), it also noted that
smooth nuclear contours in HGUC cells could be a potential pitfall in
the evaluation of urine cytology specimens, as markedly irregular
nuclear contours were identified in 83% of specimens. However,
both of these studies did not restrict their evaluation to upper uri-
nary tract specimens or substratify their findings between lower and
upper tract specimens. Nonetheless, the findings of these studies
also suggest that perhaps more fluid application of TPS diagnostic
criteria, in contrast to strict adherence to all its diagnostic criteria, as
well as potential revisions of diagnostic criteria in future iterations of
TPS may increase the diagnostic accuracy of urine cytology.
A potential revision of diagnostic criteria for urothelial carcinoma
in both upper and lower urinary tract may affect not only diagnostic
accuracy but also reproducibility. More studies are needed to establish
the effect TPS has had on diagnostic accuracy and inter-observer vari-
ability, as well as to further evaluate key morphologic features, such
as the presence or absence of nuclear contour irregularities, that can
affect diagnostic accuracy in upper urinary tract cytology specimens
compared with lower urinary tract specimens. Modification of diag-
nostic criteria based on the source of urinary cytology specimens may
enhance the utility of urine cytology and eventually help develop clini-
cally meaningful management guidelines for patient care.
Precis
The Paris System introduced diagnostic criteria for urine cytology to
improve reproducibility among pathologists. However, modifications
to diagnostic criteria, particularly in the upper urinary tract may
enhance its diagnostic accuracy.
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